Testosterone undecanoate: A useful tool for testosterone administration in rats

Experimental and Clinical Endocrinology and Diabetes

Volumn 111, Issue 4, 2003, Pages 203-208

  Callies, Frank ^a   Kollenkirchen, U ^b   Von zur Muhlen C ^a   Tomaszewski, M ^a   Beer, S ^a   Allolio, B ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Pellets; Pharmacokinetic; Testosterone; Testosterone propionate; Testosterone undecanoate

Indexed keywords

TESTOSTERONE UNDECANOATE;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EXPERIMENTAL TEST; INJECTION; KINETICS; MALE; MEASUREMENT; NONHUMAN; ORCHIECTOMY; PRIORITY JOURNAL; RAT; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE;

ANABOLIC AGENTS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MALE; ORCHIECTOMY; RATS; RATS, WISTAR; TESTOSTERONE; TESTOSTERONE PROPIONATE;

EID: 0038604200     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40464     Document Type: Article

References (14)

1. Adams MR, Williams JK, Kaplan JR. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arteriscler Thromb Vasc Biol 1995; 15: 562-570
2. Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: review. Atherosclerosis 1996; 25: 1-13
3. Bagatell CJ, Bremner WJ. Androgens in men: uses and abuses. N Engl J Med 1996; 334: 707-714
4. Behre HM, Abshagen K, Oettel M, Hubler D, Nieschlag E. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. Europ J Endocrinol 1999; 140: 414-419
5. Gill RK, Turner RT, Wronski TJ, Bell NH. Orchiectomy markedly reduces the concentration of the three isoforms of transforming growth factor beta in rat bone, and reduction is prevented by testosterone. Endocrinology 1998; 139: 546-550
6. Hügel S, Reincke M, Stromer H, Winning J, Horn M, Dienesch C, Mora P, Schmidt HH, Allolio B, Neubauer S. Evidence against a role of physiological concentrations of estrogen in post-myocardial infarction remodeling. JACC 1999; 34: 1427-1434
7. Kwan M, Greenleaf WJ, Mann J, Crapo L, Davidson JM. The nature of androgen action on male sexuality: a combined laboratory self report study on hypogonodal men. Endocrinology 1983; 57: 557-562
8. Notelovitz M. Effects of estrogen/androgen therapy on bone mineral density parameters. J Reprod Med 2001; 46: 325-331
9. Remmers DE, Cioffi WG, Bland KI, Wang P, Angele MK, Chaudry IH. Testosterone: the crucial hormone responsible for depressing myocardial function in males after trauma hemorrhage. Annals Surg 1998; 227: 790-799
10. Robaire B, Ewing LL, Irby DC, Desjardins C. Interactions of testosterone and estradiol-17β on the reproductive tract of the male rat. Biol Reproduct 1979; 21: 455-463
11. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, Strom BL. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 2000; 85: 2670-2677
12. Stratton LG, Ewing LL, Desjardin C. Efficacy of testosterone-filled polydimethylsiloxane implants in maintaining plasma testosterone in rabbits. J Reprod Fert 1973; 35: 235-244
13. Sun YT, Wreford NG, Robertson DM, de Kretser DM. Quantitative cytological studies of spermatogenensis in intact and hypophysectomized rats: identififcation of androgen-dependent stages. Endocrinol 1990; 127: 1215-1223
14. Wang J, Wreford NGM, Lan HY, Atkins R, Hedger MP. Leukocyte populations of the adult rat testis following removal of the leydig cells by treatment with ethane dimethane sulfonate and subcutaneous testosterone implants. Biol Reprod 1994; 51: 551-561